The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectio... by Miquel Serra-Burriel, Gellért Perényi, Yannic Laube, Aaron P. Mitchell, Kerstin N. Vokinger

Get full text